Phase 3 Readout~month

Phase 3 Topline: A Phase 2/3, Multicenter, Randomized, Active-Controlled, Open-label Study to Evaluate the Efficacy a

Indication
Primary Membranous Nephropathy

Other upcoming events for ONC

Phase 1 StartPhase 1 Start: A Phase 1, Single-dose, Open-label, Randomized, Crossover Study in Healthy Adult Participants to Eva
Phase 3 ReadoutPhase 3 Topline: A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Trial of Maintenance Treatment W
Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Compare the Efficacy and Safety of
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study of Either Cisplatin or C
Phase 3 ReadoutPhase 3 Topline: An International, Phase 3, Open-Label, Randomized Study of BGB-3111 Compared With Bendamustine Plus

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase 2/3, Multicenter, Randomized, Active-Controlled, Open-label Study to Evaluate the Efficacy a — ONC Phase 3 Readout | BioSniper